IP Library Granted Patent US 9,132,231
Granted Patent B2
US 9,132,231 · App. 13/617,126 · Granted Sep 15, 2015

Drug delivery device

Inventors: Joseph Gross (Moshav Mazor, IL); Izrail Tsals (Newtown, PA); Gilad Lavi (Rishon Letzion, IL); Gil Yigal (Gan Yavne, IL); Ehoud Carmel (Kiryat-Ono, IL)
Assignee: Alkermes Pharma Ireland Limited
A61M5/14248A61M5/158A61K33/22A61M5/1454A61M5/2046A61M5/31551A61M5/31571A61M5/31586A61M2005/1405A61M2005/1426A61M2005/14204A61M2005/14533A61M2005/31518Y10S128/12Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,132,231
App. No.
13/617,126
Granted
Sep 15, 2015
Kind
B2
Abstract

A drug delivery device having a housing containing a gas generator controlled by an electronic controller. The gas generator generates gas into a reciprocable chamber, whereby reciprocation of the chamber causes a lever to reciprocate a pawl, and this action causes a ratchet to undergo incremental advancement. The device may also be provided with manual control for delivering a bolus dose of drug when necessary.

Claims (31)

1. A wearable drug delivery device, comprising:

a housing with an adherent patient surface for placing on a patient, and a reservoir disposed within the housing;

a cannula in fluid communication with the reservoir and movable relative to the patient surface between a retracted position within the housing and an exposed position in which at least a portion of the cannula extends through the patient surface outside of the housing;

a piston slidably supported within the reservoir and operable to expel a drug from the reservoir;

a first drive member movably disposed within the housing and having a first portion; and

a second drive member at least partially disposed within the reservoir and having a second portion that is slidingly engageable with the first portion of the first drive member;

wherein the first and second drive members cooperate to slidably displace the piston in a first linear direction to expel a drug from the reservoir; and

wherein the first drive member engages the second drive member to prevent the piston from moving in a second direction opposite to the first linear direction.

2. The device according to claim 1 , wherein the second drive member has an irregular surface defined by a series of peaks and troughs along the first linear direction.

3. The device according to claim 2 , wherein the first drive member continuously engages the irregular surface of the second drive member.

4. The device according to claim 2 , wherein the first drive member slidably engages the irregular surface of the second drive member.

5. The device according to claim 1 , wherein the first drive member is slidable relative to the second drive member for expelling a drug from the reservoir.

6. The device according to claim 1 , wherein the cannula is retractable into the housing subsequent to the expelling of a drug from the reservoir.

7. The device according to claim 1 , wherein the entire first member is rotatably moveable relative to the reservoir and the patient surface.

8. The device according to claim 1 , wherein the first drive member comprises a reciprocable lever.

9. The device according to claim 1 , wherein the reservoir comprises a prefilled cartridge.

10. The device according to claim 1 , further comprising a controller to effect rotational movement of the first drive member.

11. A method of manufacturing a wearable drug delivery device, comprising:

providing a housing having a reservoir disposed therein, the reservoir having a piston slidably supported therein that is operable to expel a drug from the reservoir;

providing an adherent patient surface on the housing for adhering the device to the patient;

providing a movable a cannula in the housing, the cannula being movable from a retracted position within the housing to an exposed position in which at least a portion of the cannula extends through the patient surface outside of the housing;

fluidly connecting the cannula to the reservoir;

providing a first drive member to be displaceable within the housing, the first drive member having a first portion;

providing a second drive member at least partially within the reservoir, the second drive member having a second portion that is slidingly engageable with the first portion of the first drive member;

wherein providing the first and second drive members comprises:

operatively connecting the first and second drive members to cooperate to slidably displace a piston in the reservoir in a first linear direction to expel a drug from the reservoir; and

engaging the first drive member with the second drive member to prevent the piston from moving in a second linear direction opposite to the first linear direction.

12. The method according to claim 11 , wherein the second portion of the second drive member comprises an irregular surface defined by a series of peaks and troughs along the first linear direction; and

wherein the first portion of the first drive member slidably engages the irregular surface of the second drive member.

13. The method according to claim 11 , wherein the reservoir comprises a prefilled cartridge, and the method further comprises prefilling the cartridge and subsequently placing the prefilled cartridge into the housing.

14. The method according to claim 11 , further comprising providing a gas generator and a return spring in the housing to rotatably move the first drive member.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2015
From: LAVI, GILAD; YIGAL, GIL; CARMEL, EHOUD; TSALS, IZRAIL
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 035456/0922 →
CHANGE OF NAME Recorded Apr 21, 2015
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035457/0194 →
ASSET TRANSFER AGREEMENT Recorded Apr 21, 2015
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 035467/0113 →
NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS Recorded Apr 21, 2015
From: EDT PHARMA HOLDINGS
To: EDT PHARMA HOLDINGS
Reel/Frame 035467/0198 →
NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS Recorded Apr 21, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035467/0226 →
Priority Claims (1)
IE 980211 · Mar 23, 1998 · national
Continuity (6)
Continuation 13184479 · Jul 15, 2011
Continuation 12121545 · May 15, 2008
Division 10461040 · Jun 13, 2003
Division 09275464 · Mar 23, 1999
Provisional Application 60079047 · Mar 23, 1998
Related Publication 20130012873A1 · Jan 10, 2013